DKK2 and colorectal carcinoma: We demonstrated that the DKK2 blockade with the anti-DKK2 antibody 5F8 was effective in suppressing tumor progression using a syngeneic CRC model grafted with mouse colon cancer cell MC38 and a genetic benign CRC model using the ApcMin/+ mice [12,13].